


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 5 Aug 2015
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
HSMN NewsFeed - 5 Aug 2015
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
HSMN NewsFeed - 4 Aug 2015
Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer
Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer
HSMN NewsFeed - 3 Aug 2015
Omidria(R) Approved for Commercialization Throughout the European Union and Additional Countries
Omidria(R) Approved for Commercialization Throughout the European Union and Additional Countries
HSMN NewsFeed - 30 Jul 2015
Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics
Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics
HSMN NewsFeed - 29 Jul 2015
Unum Therapeutics Names Geoffrey Hodge as Senior Vice President, Operations
Unum Therapeutics Names Geoffrey Hodge as Senior Vice President, Operations
HSMN NewsFeed - 23 Jul 2015
RaNA Therapeutics Secures $55 Million in Oversubscribed Series B Financing
RaNA Therapeutics Secures $55 Million in Oversubscribed Series B Financing
HSMN NewsFeed - 22 Jul 2015
Wilson Therapeutics Announces the Appointment of Dr. Carl Bjartmar as Chief Medical Officer
Wilson Therapeutics Announces the Appointment of Dr. Carl Bjartmar as Chief Medical Officer
HSMN NewsFeed - 21 Jul 2015
Dauntless Pharmaceuticals and Aegis Therapeutics Announce Licensing Agreement
Dauntless Pharmaceuticals and Aegis Therapeutics Announce Licensing Agreement
HSMN NewsFeed - 20 Jul 2015
BioMarin Provides Program Update for Talazoparib in Metastatic Breast Cancer
BioMarin Provides Program Update for Talazoparib in Metastatic Breast Cancer
HSMN NewsFeed - 20 Jul 2015
BioSpecifics Announces Approval of XIAFLEX(R) in Japan for the Treatment of Dupuytren's Contracture
BioSpecifics Announces Approval of XIAFLEX(R) in Japan for the Treatment of Dupuytren's Contracture
HSMN NewsFeed - 19 Jul 2015
Sorrento Announces Departure of Mr. George Uy to become CEO of Start-up Company
Sorrento Announces Departure of Mr. George Uy to become CEO of Start-up Company
HSMN NewsFeed - 16 Jul 2015
Relmada Therapeutics Appoints Charles J. Casamento to Its Board of Directors
Relmada Therapeutics Appoints Charles J. Casamento to Its Board of Directors
HSMN NewsFeed - 16 Jul 2015
Immunocore Secures $320 Million (£205 Million) in Europe's Largest Private Life Sciences Financing
Immunocore Secures $320 Million (£205 Million) in Europe's Largest Private Life Sciences Financing
HSMN NewsFeed - 16 Jul 2015
Exelixis Appoints Chris Senner as Executive Vice President and Chief Financial Officer
Exelixis Appoints Chris Senner as Executive Vice President and Chief Financial Officer
HSMN NewsFeed - 15 Jul 2015
Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research
Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research
HSMN NewsFeed - 9 Jul 2015
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
HSMN NewsFeed - 8 Jul 2015
Synergy Pharmaceuticals Appoints Troy Hamilton as Chief Commercial Officer
Synergy Pharmaceuticals Appoints Troy Hamilton as Chief Commercial Officer
HSMN NewsFeed - 7 Jul 2015
Abingworth Appoints Tim Haines and Kurt von Emster as Joint Managing Partners
Abingworth Appoints Tim Haines and Kurt von Emster as Joint Managing Partners
HSMN NewsFeed - 6 Jul 2015
OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development
OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development
HSMN NewsFeed - 6 Jul 2015
Tadataka Yamada, Ph.D., Former Head of GlaxoSmithKline and Takeda R&D, Re-Joins Frazier Healthcare
Tadataka Yamada, Ph.D., Former Head of GlaxoSmithKline and Takeda R&D, Re-Joins Frazier Healthcare
HSMN NewsFeed - 29 Jun 2015
Aerie Pharmaceuticals Elects Julie McHugh and Michael M. du Toit to the Company’s Board of Directors
Aerie Pharmaceuticals Elects Julie McHugh and Michael M. du Toit to the Company’s Board of Directors
HSMN NewsFeed - 26 Jun 2015
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
HSMN NewsFeed - 25 Jun 2015
Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer
Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer
HSMN NewsFeed - 19 Jun 2015
OphthaliX Signs Definitive Agreement to Acquire Improved Vision Systems Ltd.
OphthaliX Signs Definitive Agreement to Acquire Improved Vision Systems Ltd.
HSMN NewsFeed - 16 Jun 2015
Cellectar Appoints Industry Veteran Jim Caruso President and Chief Executive Officer
Cellectar Appoints Industry Veteran Jim Caruso President and Chief Executive Officer
HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
